Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies ...

Amylyx Pharmaceuticals prices public offering of common stock at $3.50 per share, aiming to raise $60M for commercialization and pipeline programs.

We warn of potential overvaluation and high capital expenditure needs for data center REIT Equinix, recommending a Sell ...

Shares of Catalyst Pharmaceuticals CPRX gained 16.7% on Wednesday after the company, along with its licensor, SERB, announced ...

Faraday Future's FX brand updates include new logo and product details for its AI-powered vehicles, with production expected ...

F5 Inc. closed $5.66 short of its 52-week high ($264.50), which the company reached on December 13th.

Catalyst Pharmaceuticals (NASDAQ:CPRX) stock jumped 15% Wednesday on news the company had reached an agreement with Teva ...